Cargando…
The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with Chronic Kidney Disease: a randomised controlled trial
BACKGROUND: Approximately 50% of patients with stage 3 Chronic Kidney Disease are 25-hydroxyvitamin D insufficient, and this prevalence increases with falling glomerular filtration rate. Vitamin D is now recognised as having pleiotropic roles beyond bone and mineral homeostasis, with the vitamin D r...
Autores principales: | Petchey, William G, Hickman, Ingrid J, Duncan, Emma, Prins, Johannes B, Hawley, Carmel M, Johnson, David W, Barraclough, Katherine, Isbel, Nicole M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804665/ https://www.ncbi.nlm.nih.gov/pubmed/20003316 http://dx.doi.org/10.1186/1471-2369-10-41 |
Ejemplares similares
-
Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)
por: Barraclough, Katherine A, et al.
Publicado: (2009) -
PREBIOTIC: a study protocol of a randomised controlled trial to assess prebiotic supplementation in kidney transplant recipients for preventing infections and gastrointestinal upset — a feasibility study
por: Chan, Samuel, et al.
Publicado: (2023) -
The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial
por: McMahon, Emma J, et al.
Publicado: (2012) -
Deficiency of 25-Hydroxyvitamin D and Dyslipidemia in Indian Subjects
por: Chaudhuri, Jaydip Ray, et al.
Publicado: (2013) -
Low 25‐Hydroxyvitamin D in Primary Hyperparathyroidism: Enhanced Conversion Into 1,25‐Hydroxyvitamin D May Not Be “True” Deficiency
por: Kabadi, Udaya M
Publicado: (2020)